Jan 14 2025 48 mins 1
This week, Jonathan is joined by Marc Hoffman, Associate Professor in Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, to discuss novel therapies for B-cell malignancies and current challenges in hemato-oncology.
Timestamps:
(00:00)-Introduction
(03:24)-What is molecular biophysics?
(07:01)-Marc’s journey into hemato-oncology
(09:36)-Advice to young doctors
(13:08)-Treatment advances in diffuse large B-cell lymphoma
(19:11)-BRUIN study: pirtobrutinib for B-cell malignancies
(26:15)-Challenges in CAR-T therapy implementation
(31:31)-A pharmaceutical perspective
(38:10)-Regulatory insights into clinical trials
(40:58)-New horizons in hemato-oncology
(44:26)-Marc’s three wishes for healthcare
